High PD-1 expression on regulatory and effector T-cells in lung cancer draining lymph nodes
The treatment of advanced nonsmall cell lung cancer (NSCLC) with PD-1/PD-L1 immune checkpoint inhibitors has improved clinical outcome for a proportion of patients. The current challenge is to find better biomarkers than PD-L1 immunohistochemistry (IHC) that will identify patients likely to benefit...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2017-05-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/3/2/00110-2016.full |